Abel Hall LLC’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.33M Sell
9,158
-909
-9% -$212K 0.4% 31
2026
Q1
$2.46M Buy
10,067
+2,515
+33% +$586K 0.52% 22
2025
Q4
$1.56M Buy
7,552
+5,292
+234% +$1.05M 0.37% 36
2025
Q3
$419K Buy
+2,260
New +$387K 0.17% 114
2025
Q2
Sell
-2,674
Closed -$443K 306
2025
Q1
$443K Buy
+2,674
New +$418K 0.27% 63
2024
Q4
Sell
-1,550
Closed -$251K 177
2024
Q3
$251K Buy
+1,550
New +$247K 0.16% 110
2024
Q2
Sell
-1,320
Closed -$209K 154
2024
Q1
$209K Buy
+1,320
New +$210K 0.16% 117

Other funds holding JNJ

Abel Hall LLC's JNJ Position: Q2 2026 in Review

Abel Hall LLC reduced its Johnson & Johnson (JNJ) stake by 9% in Q2 2026, selling an estimated $212K and leaving 9,158 shares worth $2.33M. The position accounts for 0.4% of the portfolio, ranked #31.

Abel Hall LLC first reported a position in JNJ in Q1 2024 and has held it in 7 quarters since. The position peaked at $2.46M in Q1 2026. 1,966 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Abel Hall LLC held 9,158 shares of Johnson & Johnson worth $2.33M as of Q2 2026.
  • Abel Hall LLC sold 909 Johnson & Johnson shares in Q2 2026, an estimated $212K.
  • Johnson & Johnson made up 0.4% of Abel Hall LLC's portfolio in Q2 2026, its #31 holding.
  • Abel Hall LLC first reported a position in Johnson & Johnson in Q1 2024 and has held it in 7 quarters since.
  • Abel Hall LLC's Johnson & Johnson position peaked at $2.46M in Q1 2026.
  • 1,966 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Abel Hall LLC's 13F filing for Q2 2026, filed 24 Jul 2026.